Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Related Research units
Bibliographical data
| Original language | German |
|---|---|
| Article number | 1 |
| ISSN | 0165-4608 |
| Publication status | Published - 2009 |
| pubmed | 19167615 |
|---|
